Sun Meiling
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- MicroRNA in disease regulation 2
- Co-authors
- Yi Wang (1 shared paper)Guanghui Song (1 shared paper)Juan Wang (1 shared paper)Jingjing Su (1 shared paper)Qinglin Li (1 shared paper)Chen Dong (1 shared paper)Bin Li (1 shared paper)Yawen Hu (1 shared paper)
- Journals
- Frontiers in Cellular and Infection Microbiology (1 paper)Frontiers in Oncology (1 paper)Scientific Reports (1 paper)Pathology & Oncology Research (1 paper)PLoS ONE (1 paper)
- Partner nations
- China
In The Last Decade
Sun Meiling
10 papers receiving 694 citations
Sun Meiling's Hit Papers
Peers
Comparison fields: 5 of 98
- Applied Microbiology and Biotechnology 28
- Microbiology 84
- Molecular Medicine 66
- Drug Discovery 2
- Infectious Diseases 200
Countries citing papers authored by Sun Meiling
This map shows the geographic impact of Sun Meiling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun Meiling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun Meiling more than expected).
Fields of papers citing papers by Sun Meiling
This network shows the impact of papers produced by Sun Meiling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun Meiling. The network helps show where Sun Meiling may publish in the future.
Co-authors
The 25 scholars most cited alongside Sun Meiling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus Hit paper breakdown → | 2020 | 640 |
| 2 | 2014 | 41 | |
| 3 | 2023 | 11 | |
| 4 | 2024 | 4 | |
| 5 | 2016 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2015 | 2 | |
| 8 | 2014 | 1 | |
| 9 | 2019 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2024 | 0 | |
| 12 | 2026 | 0 |
About Sun Meiling
Sun Meiling is a scholar working on Cancer Research, Clinical Biochemistry, Oncology, Molecular Biology and Genetics, having authored 12 papers that have together received 708 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), MicroRNA in disease regulation (2 papers), RNA modifications and cancer (1 paper), Advanced SAR Imaging Techniques (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper), Natural Compound Pharmacology Studies (1 paper) and Bacterial biofilms and quorum sensing (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (28 citations), Microbiology (84 citations), Molecular Medicine (66 citations), Drug Discovery (2 citations) and Infectious Diseases (200 citations). Sun Meiling has collaborated with scholars based in China. Frequent co-authors include Yi Wang, Guanghui Song, Juan Wang, Jingjing Su, Qinglin Li, Chen Dong, Bin Li, Yawen Hu, Hong Li and Yao Wang. Their work appears in journals such as Frontiers in Cellular and Infection Microbiology, Frontiers in Oncology, Scientific Reports, Pathology & Oncology Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.